JPWO2016204265A1 - 肺炎球菌補体依存性殺菌能測定方法 - Google Patents

肺炎球菌補体依存性殺菌能測定方法 Download PDF

Info

Publication number
JPWO2016204265A1
JPWO2016204265A1 JP2017524852A JP2017524852A JPWO2016204265A1 JP WO2016204265 A1 JPWO2016204265 A1 JP WO2016204265A1 JP 2017524852 A JP2017524852 A JP 2017524852A JP 2017524852 A JP2017524852 A JP 2017524852A JP WO2016204265 A1 JPWO2016204265 A1 JP WO2016204265A1
Authority
JP
Japan
Prior art keywords
capsular
complement
pneumococci
pneumococcal
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017524852A
Other languages
English (en)
Japanese (ja)
Inventor
幸宏 明田
幸宏 明田
浩 宮武
浩 宮武
貞玉 朴
貞玉 朴
ゆか 古泉
ゆか 古泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Osaka University NUC
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Osaka University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN, Osaka University NUC filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Publication of JPWO2016204265A1 publication Critical patent/JPWO2016204265A1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G01N2333/3156—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2017524852A 2015-06-18 2016-06-17 肺炎球菌補体依存性殺菌能測定方法 Pending JPWO2016204265A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015122520 2015-06-18
JP2015122520 2015-06-18
PCT/JP2016/068069 WO2016204265A1 (fr) 2015-06-18 2016-06-17 Procédé de mesure de la fonction bactéricide dépendante du complément par rapport à des pneumocoques

Publications (1)

Publication Number Publication Date
JPWO2016204265A1 true JPWO2016204265A1 (ja) 2018-06-14

Family

ID=57546079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017524852A Pending JPWO2016204265A1 (ja) 2015-06-18 2016-06-17 肺炎球菌補体依存性殺菌能測定方法

Country Status (6)

Country Link
US (1) US20180223326A1 (fr)
EP (1) EP3312287A4 (fr)
JP (1) JPWO2016204265A1 (fr)
CN (1) CN108138216A (fr)
HK (1) HK1249149A1 (fr)
WO (1) WO2016204265A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210062138A1 (en) * 2018-01-22 2021-03-04 The Research Foundation For Microbial Diseases Of Osaka University Medium for culturing pneumococcal samples

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010521972A (ja) * 2007-03-23 2010-07-01 ワイス エルエルシー 莢膜Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ多糖の生産のための短縮された精製プロセス
JP2012184236A (ja) * 2003-04-15 2012-09-27 Intercell Ag 肺炎連鎖球菌抗原
WO2014038879A1 (fr) * 2012-09-07 2014-03-13 에스케이케미칼주식회사 Procédé de production d'un polysaccharide de capsule ayant un sérotype pneumococcique
WO2014045621A1 (fr) * 2012-09-19 2014-03-27 国立大学法人大阪大学 Vaccin pneumococcique contenant la protéine a de surface pneumococcique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012184236A (ja) * 2003-04-15 2012-09-27 Intercell Ag 肺炎連鎖球菌抗原
JP2010521972A (ja) * 2007-03-23 2010-07-01 ワイス エルエルシー 莢膜Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ多糖の生産のための短縮された精製プロセス
WO2014038879A1 (fr) * 2012-09-07 2014-03-13 에스케이케미칼주식회사 Procédé de production d'un polysaccharide de capsule ayant un sérotype pneumococcique
WO2014045621A1 (fr) * 2012-09-19 2014-03-27 国立大学法人大阪大学 Vaccin pneumococcique contenant la protéine a de surface pneumococcique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CLIN. VACCINE IMMUNOL., vol. 20, no. 10, JPN6016035188, 2013, pages 1549 - 1558, ISSN: 0004174333 *
FEMS IMMUNOL. MED. MICROBIOL., vol. 50, JPN6016035189, 2007, pages 119 - 125, ISSN: 0004174334 *
INFECT. IMMUN., vol. 78, no. 12, JPN6019017162, 2010, pages 5262 - 5270, ISSN: 0004174335 *

Also Published As

Publication number Publication date
WO2016204265A1 (fr) 2016-12-22
CN108138216A (zh) 2018-06-08
EP3312287A1 (fr) 2018-04-25
HK1249149A1 (zh) 2018-10-26
US20180223326A1 (en) 2018-08-09
EP3312287A4 (fr) 2018-12-19

Similar Documents

Publication Publication Date Title
Hamel et al. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins
Wu et al. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia
Glover et al. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis
Henningham et al. Conserved anchorless surface proteins as group A streptococcal vaccine candidates
Zhang et al. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children
Wang et al. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine
Olafsdottir et al. Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice
Cui et al. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae
Georgieva et al. Antigenic variation in Streptococcus pneumoniae PspC promotes immune escape in the presence of variant-specific immunity
Ochs et al. Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae
Wang et al. Novel immunoprotective proteins of Streptococcus pneumoniae identified by opsonophagocytosis killing screen
Smith et al. Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B
Xin et al. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae
Malekan et al. Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvants
Akbari et al. Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae
Mizrachi Nebenzahl et al. Streptococcus pneumoniae cell-wall-localized phosphoenolpyruvate protein phosphotransferase can function as an adhesin: identification of its host target molecules and evaluation of its potential as a vaccine
Batista et al. Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of the Streptococcus mutans P1 surface protein
Nagai et al. Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection
Meinke et al. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens
Yu et al. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains
WO2016204265A1 (fr) Procédé de mesure de la fonction bactéricide dépendante du complément par rapport à des pneumocoques
Kazemian et al. CbpM and CbpG of Streptococcus pneumoniae elicit a high protection in mice challenged with a serotype 19F pneumococcus
Cecchini et al. Next generation vaccines: development of a novel Streptococcus pneumoniae multivalent protein vaccine
Castro et al. Recombinant Group A Carbohydrate backbone embedded into Outer Membrane Vesicles is a potent vaccine candidate targeting Group A Streptococcus from Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis
Cao et al. CD4+ T lymphocytes mediated protection against invasive pneumococcal infection induced by mucosal immunization with ClpP and CbpA

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171130

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20180213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180320

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181011

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190516

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190703

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20191217